维普期刊资源整合服务平台（V6.5）

111篇 您的检索式：作者名="Mcclung MR"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Romosozumab in postmenopausal women with osteope- nia显示文摘	McClung MR Grauer A	2014	N Engl J Med2014，370，17：	1
2	Biphosphonates in osteoporosis :recent clinical experience 显示文摘	McClung MR	2000	Expert Opin Pharmacother2000，1，2：	1
3	Effects ofrisedronate onthe risk of hip fracture in elderly women显示文摘	McClung MR Geussens P Miller PD	2001	N Eng J Med2001，344，：	1
4	Romosozumab in postmenopausal women with low bone mineral density 显示文摘	Mcclung MR Grauer A Boonen S	2014	N Engl J Med2014，370，5：	1
5	Denosumab for prevention of fractures in postmenopausal womenwith osteoporosis显示文摘	Cummings SR San Martin J McClung MR	2009	N Engl J Med2009，361，：	1
6	Fracture risk remains reduced one year after discontinuation of risedronate显示文摘	Watts NB Chines A Olszynski WP McKeever CD McClung MR Zhou X Grauer A		0，，：	1
7	Denosumab for prevention of fractures in postmenopausal women with osteoporosis显示文摘	Cummings SR San Martin J McClung MR et ai	2009	Obestetrical&Gynecdogical Survey2009，64，12：	1
8	Denosumab for prevention of fractures in postmenopausal women with osteoporosis显示文摘	Cummings SR San Martin J McClung MR	2009	N Engl J Med2009，361，8：	1
9	Quantitative ultrasound of the heel:correlation with densitometric measurements at different skeletal sites显示文摘	Faulkner KG McClung MR Coleman LJ	1994	Osteoporos Int1994，4，1：	1
10	Denosumab for prevention of fractures in postmenopausal women with osteoporosis 显示文摘	Cummings SR San Martin J McClung MR	2009	N Engl J Med2009，361，8：	1
11	Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD显示文摘	Lewiecki EM Miller PD McClung MR	2007	J Bone Miner Res2007，22，12：	1
12	Denosumab for prevention of fractures in postmenopausal women with osteoporosis 显示文摘	Cummings SR San Martin J McClung MR	2009	N Engl J Ned2009，361，8：	1
13	The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis显示文摘	Kendler DL McClung MR	2002	Calcif Tissue Int2002，71，2：	1
14	Denosumab for prevention of fractures in postmenopausal women with osteoporosis显示文摘	CUMMINGS SR SAN MJ MCCLUNG MR et ol	2009	N Engl J Med2009，361，8：	1
15	Efficacy and safety of risedronate 150mg once a month in the treat- ment of postmenopausal osteoporosis 显示文摘	Delmas PD McClung MR Zanchetta JR	2008	Bone2008，42，1：	1
16	Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD显示文摘	LEWIECKI EM MILLER PD McCLUNG MR	2007	J Bone Miner Res2007，22，12：	1
17	Odanaeatib in postmenopausal women with low bone mineral density: a review of current clinical evidence 显示文摘	Zerbini CA McClung MR	2013	Ther Adv Musculoskelet Dis2013，5，4：	1
18	The relationship between bone mineral density and fracture risk显示文摘	Mcclung MR	2005	Curr Osteoporos Rep2005，3，2：	1
19	Romosozumab in postmeno- pausal women with low bone mineral density 显示文摘	McClung MR Grauer A Boonen S	2014	N Engl J Med2014，370，5：	1
20	Alendrohate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling显示文摘	CHESNUT CH McCLUNG MR ENSRUD KE	1995	Am J Med1995，99，2：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示